The Valley Desk

NCT04410445 · Interventional trial

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

Overall registry status Terminated

Phase 3

Conditions Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov